BTIG Research initiated coverage on shares of Histogenics Corp (NASDAQ:HSGX) in a research report released on Friday morning, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $13.00 price objective on the stock. On Wednesday shares of Histogenics Corporation (NASDAQ:HSGX) closed at $7.11.
Cleveland BioLabs, Inc. (NASDAQ: CBLI) announced that at a special meeting of stockholders held on January 27, 2015, stockholders authorized the Company’s Board of Directors to effect a reverse stock split of the Company’s common stock at a ratio in the range of 1:2 to 1:20. Cleveland BioLabs, Inc. (NASDAQ:CBLI) in last trading activity moved down -22.71% to close at $3.71. Company weekly performance is -33.75% while its quarterly performance stands at -55.83%. Cleveland BioLabs, Inc. (NASDAQ:CBLI) is -78.68% away from its 52 week high.
On last trading day Theravance Inc. (NASDAQ:THRX) moved down -4.70% to close at $10.94. Its volatility for the week is 6.06% while volatility for the month is 5.83%. THRX’s sales growth for past 5 years was -27.00% and its EPS growth for past 5 years was -1.80%. Theravance Inc. (NASDAQ:THRX) monthly performance is -27.21%.
Celsion Corporation (NASDAQ:CLSN) on 13 January has announced the submission of its Phase I clinical trial protocol to the U.S. Food and Drug Administration (FDA) for GEN-1, a DNA-based immunotherapy for cancer treatment. Celsion Corp. (NASDAQ:CLSN) has 0.30% insider ownership while its institutional ownership stands at 28.60%. In last trading activity company’s stock closed at $2.20.
On January 22, 2015, Samuel F. Colin, M.D. notified VIVUS, Inc., VIVUS Inc. (NASDAQ:VVUS) or the Company, of his decision to resign from the Company’s Board of Directors, effective immediately. On last trading day VIVUS Inc. (NASDAQ:VVUS) moved down -2.94% to close at $2.64. Its volatility for the week is 5.88% while volatility for the month is 6.41%. VVUS’s sales growth for past 5 years was -0.60% and its EPS growth for past 5 years was -65.30%. VIVUS Inc. (NASDAQ:VVUS) monthly performance is -10.81%.